홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
TARS
#1666
Tarsus Pharmaceuticals, Inc. Common Stock
72.500
0
USD
-0.21%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-0.21%
월간 변동
+5.82%
6달 변화
+9.75%
년간 변동율
+9.75%
이전 종가
72.650
0
Open
72.485
0
Bid
Ask
Low
72.485
0
High
73.150
0
양
33
마켓
주식
헬스케어
TARS
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
20.5 M
20.71 M
26.73 M
34.22 M
38.38 M
42.56 M
—
Valuation ratios
Enterprise value
679.26 M
294.62 M
334.13 M
496.64 M
2.1 B
3.38 B
9.62 B
Price to earnings ratio
—
-33.58
-5.72
-4.36
-18.04
-51.5
-118
Price to sales ratio
—
8.11
13.75
33.95
11.38
7.58
28.09
Price to cash flow ratio
—
123.39
-7.24
-5.04
-25.08
-274.78
-367.61
Price to book ratio
—
2.77
1.84
3.01
9.27
9.96
15.19
EBITDA 비율에 대한 기업 가치
-25.34
-25.52
-4.97
-3.2
-16.5
-44.58
-104.72
Profitability ratios
Return on assets %
-0.16
-0.08
-0.27
-0.51
-0.31
-0.12
-0.13
Return on equity %
-0.16
-0.08
-0.32
-0.69
-0.51
-0.19
-0.2
Return on invested capital %
-1 906.71
-566.25
-2 112.36
-2 838.11
-1 840.82
-617.61
—
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
-21.32
-242.92
-820.53
-65.9
-15.72
-72.66
EBITDA margin %
—
-20.24
-244.4
-831.43
-67.27
-16.4
-75.25
Net margin %
—
-24.25
-240.51
-778.89
-63.16
-14.72
-68
Liquidity ratios
Quick ratio
—
—
—
6.85
4.39
3.82
18.83
Current ratio
31.68
15.33
14.61
6.93
4.42
3.85
18.97
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.33
0.13
0.07
0.57
0.96
0.89
Solvency ratios
Debt to assets ratio
—
—
0.09
0.12
0.19
0.15
0.59
Debt to equity ratio
—
—
0.11
0.16
0.32
0.24
0.92
Long term debt to total assets ratio
—
—
0.09
0.11
0.19
0.13
0.55
Long term debt to total equity ratio
—
—
0.1
0.15
0.32
0.21
0.85
Per share metrics
Operating cash flow per share
—
0.18
-1.99
-4
-2.21
-0.3
-0.33
EBIT per share
—
-0.59
-2.55
-4.87
-3.21
-1.7
-1.72
EBITDA per share
—
-0.56
-2.56
-4.94
-3.27
-1.77
-1.78
Total debt per share
—
—
0.83
1.08
1.93
1.99
7.47
Cash per share
—
8.36
8.82
7.74
7.75
9.99
38.78
Net current asset value per share
—
8.56
9.15
8.72
9.49
12.51
47.71
Tangible book value per share
—
8.11
7.84
6.57
5.75
8.04
31.89
Working capital per share
—
8
8.53
7.46
7.34
9.26
37.39
Book value per share
—
8.11
7.84
6.7
5.97
8.22
32.64
뉴스
Tarsus Pharmaceuticals: Marketing Spend Bears Fruit, Pipeline Progresses (NASDAQ:TARS)
Gold Stocks, AI Leader Broadcom Among 25 Newcomers To Best Stock Lists
Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating
Cloudflare Qualifies For Two Top Stock Lists, Leads 13 Newcomers To IBD 50, Stock Spotlight, More
Tarsus Pharmaceuticals, Barclays 컨퍼런스 발표: 성장 전략 및 과제
Tarsus Pharmaceuticals at Barclays Conference: Strategic Growth and Challenges
타르수스 제약 COO, 64만 1천 달러 상당의 주식 매도
Tarsus Pharma COO Neervannan Seshadri sells $641k in stock
타르수스 제약, TD Cowen 컨퍼런스서 블록버스터 성장 조준
Tarsus Pharmaceuticals at TD Cowen Conference: Eyeing Blockbuster Growth
Maker Of Eye Drops Has Sights On Buy Point
Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists